COVID-19 stokes inflammasomes.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
The poor success rate of treating patients with aggressive sepsis in SARS-CoV-2 infections has highlighted again the challenges of managing systemic inflammatory conditions. In this issue of JEM, Rodrigues et al. (https://doi.org/10.1084/jem.20201707) discuss the role of inflammasome activation in COVID-19 disease severity, opening new possibilities for therapeutic management of sepsis syndromes.
Description
Keywords
Journal Title
J Exp Med
Conference Name
Journal ISSN
0022-1007
1540-9538
1540-9538
Volume Title
218
Publisher
Rockefeller University Press
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Sponsorship
Wellcome Trust (108045/Z/15/Z)